StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
GlaxoSmithKline (GSK) and Pfizer (PFE) announce FDA approval of ViiV Healthcare's Dovato for treatment-naïve HIV-1 adults
April 8, 2019 4:54 PM
ViiV Healthcare today announced that the US Food and Drug Administration (FDA) approved Dovato, a complete, once-daily, single-tablet regimen of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Management Comments
Next Articles
US FDA approves ViiV Healthcare’s Dovato (dolutegravir/lamivudine), the first, once-daily, single-tablet, two-drug regimen for treatment-naïve HIV-1 adults
April 8, 2019 4:49 PM
FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment
April 8, 2019 3:35 PM
